Skip to main content
SpringerLink
Log in

Maligne Hodentumoren in der Cisplatin-Ära: Todesursachen und Letalität in einer Kohortenstudie

Malignant testicular neoplasms in the cisplatin era: causes of death and mortality in a cohort study

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

Verwendete Literatur

  1. Adams SC, DeLorey DS, Davenport MH, Farey AS, North S, Courneya KS (2018) Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors. Br J Cancer 118:1313–1321

    Article  Google Scholar 

  2. Chau C, Cahtomas R, Wheater M, Klingbiel D, Fehr M, Bennett J, Markham H, Lee C, Crabb SJ, Geldart T (2015) Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience. Ann Oncol 26:1865–1870

    Article  CAS  Google Scholar 

  3. Einhorn LH, Donohue J (1977) Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87(3):293–298. https://doi.org/10.7326/0003-4819-87-3-293

    Article  CAS  PubMed  Google Scholar 

  4. Fischer S, Tandstad T, Wheater M, Porfiri E, Fléchon A, Aparicio J, Klingbiel D, Skrbinc B, Basso U, Shamash J, Lorch A, Dieckmann KP, Cohn-Cedermark G, Stahl O, Chau C, Arriola E, Marti K, Hutton P, Laguerre B, Maroto P, Beyer J, Gillessen S (2017) Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma. J Clin Oncol 35:194–200

    Article  Google Scholar 

  5. Fossa SD, Gilbert E, Dores GM, Chen J, McGlynn KA, Schonfeld S, Storm H, Hall P, Holowaty E, Andersen A, Joensuu H, Andersson M, Kaijser M, Gospodarowicz M, Cohen R, Pukkala E, Travis LB (2007) Non-cancer causes of death in survivors of testicular cancer. J Natl Cancer Inst 99:533–544

    Article  Google Scholar 

  6. Fung C, Dinh P, Ardeshir-Rouhani-Fard S, Schaffer K, Fossa SD, Travis LB (2018) Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors. Adv Urol. https://doi.org/10.1155/2018/8671832

    Article  PubMed  PubMed Central  Google Scholar 

  7. Groot HJ, van Leeuwen FE, Lubberts S, Horenblas S, de Wit R, Witjes JA, Groenewegen G, Poortmans PM, Hulshof MCCM, Meijer OWM, de Jong IJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJB, Jozwiak K, van den Belt-Dusebout AW, Gietema JA, Schaapveld M (2020) Platinum exposure and cause-specific mortality among patients with testicular cancer. Cancer 126:628–639

    Article  CAS  Google Scholar 

  8. Hellesnes R, Kvammen Q, Myklebust TA, Brmnes RM, Karlsdottir A, Negaard HFS, Tandstad T, Wilsgaard T, Fossa SD, Haugnes HS (2020) Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era. Int J Cancer 147:21–32

    Article  CAS  Google Scholar 

  9. Hellesnes R, Myklebust TA, Fossa SD, Bremnes RM, Karlsdottir A, Kvammen Q, Tandstad T, Wilsgaard T, Negaard HFS, Haugnes HS (2021) Testicular cancer in the cisplatin era: causes of death and mortaility rates in a population-based cohort. J Clin Oncol 39:3561–3573

    Article  CAS  Google Scholar 

  10. Horwich A, Dearnaley DP, Sohaib A, Pennert K, Huddart RA (2013) Neoadjuvant carboplatin before radiotherapy in stage IIA and IIB seminoma. Ann Oncol 24(8):2104–2107. https://doi.org/10.1093/annonc/mdt148

    Article  CAS  PubMed  Google Scholar 

  11. Horwich A, Fossa SD, Huddart R, Dearnaley DP, Stenning S, Aresu M, Bliss JM, Hall E (2014) Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma. Br J Cancer 110:256–263

    Article  CAS  Google Scholar 

  12. Liang F, Zhang S, Xue H, Chen Q (2017) Risk of second primary cancer in cancer patients treted with cisplatin: a systematic review and meta-analysis of randomized studies. BMC Cancer 17:871

    Article  Google Scholar 

  13. Oliver RTD, Mead GM, Rustin GJS, Joffe JK, Aass N, Coleman R, Gabe R, Pollock P, Stenning SP (2011) Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results of relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study. J Clin Oncol 29:957–962

    Article  CAS  Google Scholar 

  14. Rothermundt C, Thurneysen C, Cathomas R, Müller B, Mingrone W, Hirschi-Blickendorfer A, Wehrhahn T, Ruf C, Rothschild S, Seifert B, Terbuch A, Grassmugg T, Woelky R, Fankhauser C, Kunit T, Fischer N, Inauen R, Ziegler K, Haynes A, Jüni P, Kehl J, Gillessen S (2018) Baseline characteristics and pattterns of care in testicular cancer patients: first data from the Swiss Austrian German testicular cancer cohort study (SAG TCCS). Swiss Med Wkly 148:w14640

    PubMed  Google Scholar 

  15. Schepisi G, De Padova S, De Lisi D, Casadei C, Meggiolaro E, Ruffilli F, Rosti G, Lolli C, Ravaglia G, Conteduca V, Farolfi A, Grassi L, De Giorgi U (2019) Psychosocial Issues in long-term survivors of testicular cancer. Front Endocrinol 10:113

    Article  Google Scholar 

  16. Tandstad T, Stahl O, Dahl O, Haugnes HS, Hakansson U, Karlsdottir A, Kjellman A, Langber CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Stierner U, Cavallin-Stahl E, Wahlqvist R, Wall N, Cohn-Cedermark G (2016) Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian testicular cancer group (SWENOTECA). Ann Oncol 27:1299–1304

    Article  CAS  Google Scholar 

  17. Zagars GK, Ballo MT, Lee AK, Strom SS (2004) Mortality after cure of testicular seminoma. J Clin Oncol 22:640–647

    Article  Google Scholar 

Weiterführende Literatur

  1. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2019) S3-Leitlinie Diagnostik, Therapie und Nachsorge der Keimzelltumoren des Hodens, Kurzversion 1.0. https://www.leitlinienprogramm-onkologie.de/leitlinien/hodentumoren. Zugegriffen: 10. Apr. 2022 (AWMF-Registernummer: 043/049OL)

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie und Radioonkologie, Universitätsspital Basel, Petersgraben 4, 4031, Basel, Schweiz

    Alexandros Papachristofilou &  Frank Zimmermann

Authors
  1. Alexandros Papachristofilou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank Zimmermann.

Ethics declarations

Interessenkonflikt

A. Papachristofilou und F. Zimmermann geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation

Hellesnes R, Myklebust TA, Fossa SD et al (2021). Testicular cancer in the cisplatin era: causes of death and mortality rates in a population-based cohort. JCO. 39:3561–3573.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papachristofilou, A., Zimmermann, F. Maligne Hodentumoren in der Cisplatin-Ära: Todesursachen und Letalität in einer Kohortenstudie. Strahlenther Onkol 198, 862–865 (2022). https://doi.org/10.1007/s00066-022-01957-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-022-01957-8

Search

Navigation